Received May 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
I've had Pfizer boosters which I've had a pretty significant immune responses to; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): NOV25-00240 (Novavax). A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Novavax covid-19 vaccine (Primary Immunization series complete), for Immunization. The following information was reported: IMMUNISATION REACTION (non-serious), outcome "unknown", described as "I've had Pfizer boosters which I've had a pretty significant immune responses to". Additional information: Patient was part of the original Novavax trial and following that patient was trying to get a booster. Patient have had Pfizer boosters which patient have had a pretty significant immune response to. Patient wanted to stay away from mRNA. Patient was having a hard time finding anyone that's carrying Novavax. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.